(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.
(CIDRAP News) The World Health Organization (WHO) today confirmed three fatal cases of H5N1 avian influenza in Indonesia, involving two women from Java and a boy from South Jakarta, bringing Indonesia's toll to 72 cases with 55 deaths.
(CIDRAP News) The human immune system may respond better to a vaccine for a new strain of H5N1 avian influenza if it is prepared in advance with a vaccine based on an existing H5N1 strain, the preliminary results of a government-sponsored study suggest.
(CIDRAP News) To speed emergency responses to avian influenza and other animal and plant diseases, the United Nations Food and Agriculture Organization (FAO) inaugurated a new crisis management center (CMC) at its Rome headquarters today.
(CIDRAP News) The World Health Organization (WHO) announced today that a 39-year-old Egyptian woman has H5N1 avian influenza, while officials in Indonesia reported another fatal human case there.
(CIDRAP News) Pigs and stray cats have been found infected with the H5N1 avian influenza virus in Indonesia, adding to the few previous reports of such cases, according to news services.
(CIDRAP News) In a development that could complicate avian influenza control efforts, an Indonesian official said this week that some apparently healthy chickens showed evidence of H5N1 virus infection, according to the Jakarta Post.
(CIDRAP News) Public health and infectious disease experts today called on the United States to develop a "master plan" for development of pandemic influenza vaccines in order to translate scientific advances more rapidly into improved pandemic preparedness.
(CIDRAP News) Initial tests on wild ducks in Illinois suggest they have a low-pathogenic strain of avian influenza, not the deadly H5N1 strain, federal officials said late last week.
(CIDRAP News) Recent tests suggest that an antiviral drug given by intravenous (IV) or intramuscular (IM) injection could eventually serve as another weapon against influenza, according to results presented at a conference last week.
